A clinical trial to study the effect of the drug Kamalaiku kashayam in patients having Vali manjal noi(Fatty Liver Disease)
- Conditions
- Type 2 diabetes mellitus with other specified complications,
- Registration Number
- CTRI/2021/10/037674
- Lead Sponsor
- Government Siddha Medical college
- Brief Summary
This is a single non randomised open clinical trial to study the safety and efficacy of siddha trial drug Kamalaiku kashayam. The trial drug is given 30ml twice a day for 30 days. Clinical trial is conducted after conducting the preclinical toxicity study. The trial drug Kamalaiku kashayam is mentioned in Sikicha rathna deepam. During the trial all the study related data will be recorded and documented. After the completion of trial all the data will be analysed statistically.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- All
- Target Recruitment
- 40
Subject within 20-60years, Grade 2 & Grade 1 fatty liver in USG abdomen Metabolic syndrome(Type 2 Diabetes mellitus,Obesity) Dyslipidemia.
Cirrhosis HCC Alcoholic fatty liver Portal hypertension Hepatitis (HBV,HCV infection) Hepatosplenomegaly Cholecystitis.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method It is mainly assessed by reduction in the clinical symptoms of abdominal discomfort, fat deposition, fatigue and abdominal pain 90days
- Secondary Outcome Measures
Name Time Method By comparing the fat deposition changes assessed by USG abdomen Grade 2 to Grade 1, Grade 1 to normal in liver USG study before and after treatment. 30days
Trial Locations
- Locations (1)
Arignar Anna Government hospital of Indian Medicine
🇮🇳Chennai, TAMIL NADU, India
Arignar Anna Government hospital of Indian Medicine🇮🇳Chennai, TAMIL NADU, IndiaDrKuttala vadivu CPrincipal investigator9361325072vadivubala1995@gmail.com